Ability Pharmaceuticals

About:

Ability Pharmaceuticals is a drug discovery and development company.

Website: http://www.abilitypharma.com

Twitter/X: abilitypharma

Top Investors: European Innovation Council, Capital Cell, Inveready, CDTI Innovación's INNVIERTE program, SciClone Pharmaceuticals

Description:

Ability Pharmaceuticals is a drug discovery and development company based in Barcelona, Spain. It develops human therapeutics targeting cell membranes to treat cancer and other indications with unmet medical needs. Ability Pharmaceuticals is focused on developing new drugs for the treatment of lung cancer and pancreatic cancer. The company develops Lipid Analogue Therapeutics, a new drug class that modifies the composition of the cell membrane and displays a capacity to influence the local organization of lipid structures in the cell membrane, inducing the formation of non-lamellar phase structures. Its development pipeline includes ABTL0812 product in preclinical development; and ABTL1014, a drug candidate in preclinical characterization.